Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer

ABSTRACT:

SUBMITTER: Khawaja M 

PROVIDER: S-EPMC12947236 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature